Report 2016-111 Recommendation 9 Responses
Report 2016-111: City of Irwindale: It Must Exercise More Fiscal Responsibility Over Its Spending So That It Can Continue to Provide Core Services to Residents (Release Date: November 2016)
Recommendation #9 To: Irwindale, City of
To reduce the costs of its resident prescription drug benefit program, the city council should follow the recommendations of its consultant by approving the following: align copayments by increasing those paid by residents 50 years of age and older to the same level as those paid by residents who are 49 years or younger.
1-Year Agency Response
The City will continue to explore all options for reducing these costs. As stated in the City's November 8th 2016 response letter: "...the Irwindale City Council remains committed to continuing its efforts to further reduce the costs of its resident benefit program. Irwindale staff remains vigilant in reviewing options for the program to be more cost effective, without compromising Irwindale's mission of repaying its residents for the years of exposure to the effects of mining."
- Response Date: November 2017
California State Auditor's Assessment of 1-Year Status: Will Not Implement
Irwindale overstates its efforts to reduce costs. As we state in our report, the city has been reluctant to implement changes to its prescription drug benefit program. Specifically, the city council rescinded increases it had previously made to the copayment requirement and rejected its consultant's more significant recommendations to increase the copayment for all participants to $10 and to implement a coordination of benefits that would make Irwindale's program a secondary payer to residents' private health insurance.
6-Month Agency Response
The City will continue to explore all options for reducing these costs. As stated in the City's November 8th response letter: "...the Irwindale City Council remains committed to continuing its efforts to further reduce the costs of its resident benefit program. Irwindale staff remains vigilant in reviewing options for the program to be more cost effective, without compromising Irwindale's mission of repaying its residents for the years of exposure to the effects of mining."
- Response Date: May 2017
California State Auditor's Assessment of 6-Month Status: Will Not Implement
Irwindale overstates its efforts to reduce costs. As we state in our report, the city has been reluctant to implement changes to its prescription drug benefit program. Specifically, the city council rescinded increases it had previously made to the copayment requirement and rejected its consultant's more significant recommendations to increase the copayment for all participants to $10 and to implement a coordination of benefits that would make Irwindale's program a secondary payer to residents' private health insurance.
60-Day Agency Response
The City will continue to explore all options for reducing these costs, as stated in the City's November 8th response letter: "...the Irwindale City Council remains committed to continuing its efforts to further reduce the costs of its resident benefit program. Irwindale staff remains vigilant in reviewing options for the program to be more cost effective, without compromising Irwindale's mission of repaying its residents for the years of exposure to the effects of mining."
- Response Date: January 2017
California State Auditor's Assessment of 60-Day Status: Will Not Implement
Irwindale overstates its efforts to reduce costs. As we state in our report, the city has been reluctant to implement changes to its prescription drug benefit program. Specifically, the city council rescinded increases it had previously made to the copayment requirement and rejected its consultant's more significant recommendations to increase the copayment for all participants to $10 and to implement a coordination of benefits that would make Irwindale's program a secondary payer to residents' private health insurance.
All Recommendations in 2016-111
Agency responses received are posted verbatim.